{"title":"NSCLC: novel targeted therapies offer hope for the future","authors":"Marianne Nicolson MD, FRCP, Asa Dahle-Smith BSc, Mb ChB","doi":"10.1002/fps.80","DOIUrl":null,"url":null,"abstract":"<p><b>Lung cancer remains a major healthcare challenge despite the recent reduction in incidence in the Western world and introduction of the public smoking ban in some countries. However, the complexity of tumour biology is being unravelled along with a greater understanding of molecular signalling pathways, opening up a new field of research into targeted therapies. Here the authors focus on non-small cell lung cancer (NSCLC), discussing its current management and some of the promising targeted therapies currently being investigated.</b> Copyright © 2011 John Wiley & Sons, Ltd.</p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"12 3","pages":"6-9"},"PeriodicalIF":0.0000,"publicationDate":"2011-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.80","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.80","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Lung cancer remains a major healthcare challenge despite the recent reduction in incidence in the Western world and introduction of the public smoking ban in some countries. However, the complexity of tumour biology is being unravelled along with a greater understanding of molecular signalling pathways, opening up a new field of research into targeted therapies. Here the authors focus on non-small cell lung cancer (NSCLC), discussing its current management and some of the promising targeted therapies currently being investigated. Copyright © 2011 John Wiley & Sons, Ltd.
非小细胞肺癌:新型靶向治疗为未来带来希望
肺癌仍然是一个主要的医疗保健挑战，尽管最近西方世界的发病率有所下降，一些国家实行公共场所禁烟。然而，随着对分子信号传导途径的更深入了解，肿瘤生物学的复杂性正在被揭开，为靶向治疗开辟了一个新的研究领域。在这里，作者着重于非小细胞肺癌(NSCLC)，讨论其目前的管理和一些有前途的靶向治疗目前正在研究。版权所有©2011 John Wiley &儿子,有限公司
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
